The role of Direct Oral Anticoagulant in patients with Acute Coronary Syndrome on single or dual antiplatelet regime: review of opportunities and challenges.

CONCLUSION: Cardiologists should balance the efficacy with higher risk of bleeding with more intensified DOAC therapy. Better risk characterization and timely adaptation of the regime to the patients need should be tested. Recurrent ischemic event and bleeding event risk scoring should guide individualized treatment. PMID: 32418529 [PubMed - as supplied by publisher]
Source: Current Clinical Pharmacology - Category: Drugs & Pharmacology Authors: Tags: Curr Clin Pharmacol Source Type: research